OTC Healthcare in China
Euromonitor International's OTC Healthcare in China market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 117 | Publication date: Sep 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Growing health awareness and disposable incomes fuel growth
OTC healthcare continued its healthy growth in 2008, mainly due to rising disposable income levels and growing health awareness among consumers. Robust economic development in China underpinned improving living standards, which enabled consumers to spend more on OTC healthcare. Meanwhile, consumers also became more educated about personal wellbeing via conventional mass media such as TV and newspapers as well as via emerging new media channels such as the internet. OTC healthcare manufacturers also played an important role in consumer education during the review period. Consequently, consumers gained more confidence in self-medication, leading to stronger sales of OTC healthcare.
Vitamins and dietary supplements lead growth
Vitamins and dietary supplements accounts for the largest share of sales in overall OTC healthcare. Within this, calcium supplements represents almost a fifth of total vitamins and dietary supplements value sales. Apart from growing health-consciousness, consumer education is also crucial for sales growth. Due to education campaigns, consumers began to realise the deficiency in calcium intake in the Chinese diet because of its lower intake of dairy products. Vitamins and dietary supplements continued to see strong growth towards the end of the review period, contributing greatly to overall robust growth for OTC healthcare.
Amway leads fragmented OTC healthcare
OTC healthcare in China is fairly fragmented, with most players having a small share except Amway (China) Co Ltd. Amway enjoys a strong lead thanks to its performance in vitamins and dietary supplements. After obtaining a direct selling licence at the end of 2005, Amway restructured its direct selling system in China. The company adopted a diversified network involving direct sellers and retailing outlets, with 207 Amway shops operating in over 170 cities across China. The established Amway brand, aided by its continuous support of charity, also helped the company to gain a strong foothold in OTC healthcare in China.
Chemists/pharmacies lead but direct selling grows fastest
As the traditional distribution channel for OTC healthcare, chemists/pharmacies continued to lead value sales, thanks to their easy access and clear product displays on shelves. However, direct selling saw the fastest growth in share, benefiting from offering personal service and convenience. The leading direct selling companies, such as Amway, also helped strengthen the development of this non-store retailing channel. Internet retailing also emerged in China in the review period but remained insignificant alongside powerful direct selling.
Steady growth for forecast period
Even though some product areas are expected to see saturation in the forecast period, OTC healthcare overall is forecast to maintain steady growth. Increasing health-consciousness will be the key driver of growth. With improving living conditions, consumers will be able to better afford OTC healthcare. OTC healthcare will also increasingly be used to boost consumers’ immunity and enhance their personal wellbeing on a daily basis. Widening penetration is also expected to boost sales, with growing rural distribution. OTC healthcare was under-developed in rural areas in the review period.
Table of contents
OTC HEALTHCARE IN CHINA : MARKET INSIGHT
EXECUTIVE SUMMARY
Growing health awareness and disposable incomes fuel growth
Vitamins and dietary supplements lead growth
Amway leads fragmented OTC healthcare
Chemists/pharmacies lead but direct selling grows fastest
Steady growth for forecast period
KEY TRENDS AND DEVELOPMENTS
Rising health-consciousness and self-medication
Convenience becomes increasingly important
Lifestyle changes shape growth
Players increasingly focus on specific consumer targets
Deep-rooted tradition impacts OTC healthcare
TERRITORY KEY TRENDS AND DEVELOPMENTS
East China
Mid China
North and Northeast China
Northwest China
South China
Southwest China
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 Sales of OTC Healthcare by Region: Value 2003-2008
Table 6 Sales of OTC Healthcare by Region: % Value Growth 2003-2008
Table 7 OTC Healthcare Company Shares by Value 2004-2008
Table 8 OTC Healthcare Brand Shares by Value 2005-2008
Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
Table 13 Forecast Sales of OTC Healthcare by Region: Value 2008-2013
Table 14 Forecast Sales of OTC Healthcare by Region: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Self-medication and Preventative Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - CHINA
AMWAY (CHINA) CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Amway (China) Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Amway (China) Co Ltd: Competitive Position 2008
BRISTOL-MYERS SQUIBB (SHANGHAI) TRADING CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 6 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 7 Bristol-Myers Squibb (Shanghai) Trading Co Ltd: Competitive Position 2008
GLAXOSMITHKLINE (TIANJIN) PHARM CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 8 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 9 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 10 GlaxoSmithKline (Tianjin) Pharm Co Ltd: Competitive Position 2008
JIANGZHONG PHARMACEUTICAL CO - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Jiangzhong Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Jiangzhong Pharmaceutical Co Ltd: Competitive Position 2008
SANJIU ENTERPRISE GROUP - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Sanjiu Enterprise Group: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 Sanjiu Enterprise Group: Competitive Position 2008
TIANJIN TIANSHI BIOLOGICAL DEVELOPMENT CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Tianjin Tianshi Biological Development Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Tianjin Tianshi Biological Development Co Ltd: Competitive Position 2008
TIBET LINZHI QIZHENG TIBETAN MEDICINE FTY - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 17 Tibet Linzhi Qizheng Tibetan Medicine Fty: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 18 Tibet Linzhi Qizheng Tibetan Medicine Fty: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 19 Tibet Linzhi Qizheng Tibetan Medicine Fty: Competitive Position 2008
WYETH PHARMACEUTICAL CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 20 Wyeth Pharmaceutical Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 21 Wyeth Pharmaceutical Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 22 Wyeth Pharmaceutical Co Ltd: Competitive Position 2008
XIAN JANSSEN PHARMACEUTICAL LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 23 Xian Janssen Pharmaceutical Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 Xian Janssen Pharmaceutical Ltd: Competitive Position 2008
YUNNAN BAIYAO GROUP CO LTD - OTC HEALTHCARE - CHINA
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Yunnan Baiyao Group Co Ltd: Key Facts
COMPANY BACKGROUND
PRODUCTION
Summary 26 Yunnan Baiyao Group Co Ltd: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 27 Yunnan Baiyao Group Co Ltd: Competitive Position 2008
ANALGESICS IN CHINA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 15 Sales of Analgesics by Subsector: Value 2003-2008
Table 16 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 17 Herbal vs Standard Topical Analgesics 2003-2008
Table 18 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 19 Analgesics Company Shares by Value 2004-2008
Table 20 Analgesics Brand Shares by Value 2005-2008
Table 21 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 22 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN CHINA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 23 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 24 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 25 Sales of Decongestants by Type: Value 2003-2008
Table 26 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 27 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 28 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 29 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 31 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 33 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN CHINA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 34 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 35 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 36 Herbal vs Standard Digestive Remedies 2003-2008
Table 37 Digestive Remedies Company Shares by Value 2004-2008
Table 38 Digestive Remedies Brand Shares by Value 2005-2008
Table 39 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 40 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN CHINA
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 41 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 42 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 43 Herbal vs Standard Medicated Skin Care 2003-2008
Table 44 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 45 Medicated Skin Care Company Shares by Value 2004-2008
Table 46 Medicated Skin Care Brand Shares by Value 2005-2008
Table 47 Acne Treatments Brand Shares by Value 2005-2008
Table 48 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 49 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN CHINA
HEADLINES
TRENDS – VITAMINS
TRENDS – DIETARY SUPPLEMENTS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 50 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 51 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 52 Folic Acid v Other B Vitamins 2004-2008
Table 53 Dietary Supplements by Positioning 2006-2008
Table 54 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 55 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 56 Vitamins Brand Shares by Value 2005-2008
Table 57 Dietary Supplements Brand Shares by Value 2005-2008
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 59 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN CHINA
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
EYE CARE IN CHINA
SECTOR DATA
Table 60 Sales of Eye Care by Subsector: Value 2003-2008
Table 61 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 62 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 63 Eye Care Company Shares by Value 2004-2008
Table 64 Eye Care Brand Shares by Value 2005-2008
Table 65 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 66 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN CHINA
ADULT MOUTH CARE IN CHINA
SECTOR DATA
Table 67 Sales of Adult Mouth Care: Value 2003-2008
Table 68 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 69 Adult Mouth Care Company Shares by Value 2004-2008
Table 70 Adult Mouth Care Brand Shares by Value 2005-2008
Table 71 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 72 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN CHINA
SECTOR DATA
Table 73 Sales of Calming and Sleeping Products: Value 2003-2008
Table 74 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 75 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 76 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 77 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 78 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN CHINA
SECTOR DATA
Table 79 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 80 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 81 Wound Treatments Company Shares by Value 2004-2008
Table 82 Wound Treatments Brand Shares by Value 2005-2008
Table 83 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 84 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN CHINA
EMERGENCY CONTRACEPTION IN CHINA
SECTOR DATA
Table 85 Sales of Emergency Contraception: Value 2003-2008
Table 86 Sales of Emergency Contraception: % Value Growth 2003-2008
Table 87 Emergency Contraception Company Shares by Value 2004-2008
Table 88 Emergency Contraception Brand Shares by Value 2005-2008
Table 89 Forecast Sales of Emergency Contraception: Value 2008-2013
Table 90 Forecast Sales of Emergency Contraception: % Value Growth 2008-2013
OTC TRIPTANS IN CHINA